SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Larry Liebman who wrote (432)3/13/1997 11:48:00 AM
From: Old Fox   of 6136
 
The Schwab 500 research alert I referred to yesterday was from Brown Brothers Harriman analyst Robert LeBoyer(sp?). It was his opinion the stock had reached a fair price in part due to these three reasons: 1. Successful secondary of the competition, Vertex. 2. The fact that Doug Lind had left PW and left about 1,500,000 shares of AGPH in the retail accounts of PW which no longer have constant support from the brokerage house since its guru had left. 3. A general profit taking in biotechs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News